China, Sept. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A multicenter observational study of Nacetylcysteine for severe liver injury related to anti-tumor therapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600131967
Registration Time: 2026/09/08
Type: Observational study
Primary Sponsor: West China Hospital of Sichuan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342358
Published by HT Digital Content Services with permission from Health Daily Digest....